Schedule 13G ownership disclosure

SELLAS Life Sciences Group, Inc.

Security class unavailable · CUSIP: 81642T100

Event date: 2019-06-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,000,000
Percent of class
9.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-19-004559
Form type
SC 13G/A
Filer
Altium Capital Management LLC
CIK
CIK 1746382
Filed
Jun 24, 2019
Reporting period
Jun 14, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub